FeesSafety
Pluang+

Gram (GRAM) token price dips 2.18% to $1.20 in 24-hour trading range.

Market News
02 Nov 2026, 14:23 WIB
Tokenpost
View Source
Bearish
Gram (GRAM) token price dips 2.18% to $1.20 in 24-hour trading range.

The Gram (GRAM) cryptocurrency token was priced at $1.20 as of 5:26 a.m. ET on November 2, showing a 2.18% decrease over the previous 24 hours. The token's trading range during this period was between $1.20 and $1.23. This slight price drop reflects short-term market fluctuations in the digital asset space. Investors should watch for further movements as the market evolves.

Gram cryptocurrency price data as of Nov 02, 2026 19:42 WIB provides context for readers. For those following the broader crypto market, Pluang's snapshot shows that out of 50 major cryptocurrencies, 7 rose and 42 fell today. Notable movers include CRV at Rp4.969 with a 1-day change of -4.46%, LUNC at Rp0,75 down 4.34%, and AAVE at Rp2.388.769 down 4.02%.

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
45 minutes ago
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...

Company Fundamentals
Neutral
45 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
45 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
45 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
45 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App